Iron Oxide Nanoparticles in Lipid Delivery System May Lead to Better Cancer Treatment

Lipids are frequently used to form drug carrying nanoparticles because of their favorable biocompatibility. However, construction of such drug-carrying lipid…


2019 World Molecular Imaging Conference Poster

This study is the Company's first reported results demonstrating that the anti-HER2 nanoparticles used in Imagion's Magsense™ technology, which provide…


Imagion Biosystems receives order related to cancer treatment

Imagion Biosystems today announced that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has issued an extended purchase order to…


HER2 Nanoparticle Safety and Specificity Data Presented at AACR 2019

Marie Zhang, PhD, Vice President of Research and Clinical Development at Imagion Biosystems, presented the poster "HER2 Functionalized Nanoparticles Are Safe…


MagSense Technology Animation

. Cancer treatments are most effective, and patient outcomes are improved, when tumors are detected early. Imagion Biosystems is developing the MagSense®…


Imagion Biosystems Hits Nanoparticle Formulation Milestone

Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce it has…


Sandia Collaboration In The News

Sandia National Laboratories has published an article on the longstanding and productive collaboration between Sandia’s Center for Integrated Nanotechnologies…


Imagion Biosystems December 2017 Quarterly Update

In accord with ASX requirements, Imagion Biosystems' 2017 quarterly update was lodged with the Australian Securities Exchange on 31 January 2018. The update…


Imagion Biosystems Launches New PEG-Coated Iron-Oxide Nanoparticles for Life Science Research Applications

Slow rate of clearance makes new product ideal for magnetic particle imaging. Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare…


Imagion Biosystems Secures Nanoparticle Manufacturer

Imagion Biosystems Limited (Imagion, ASX:IBX) has entered into a Master Service Agreement with ChemConnection BV, a Dutch contract manufacturing organization…